WO/2009/126514 is referenced by 8 patents.

The invention relates to triazine and pyrimidine derivatives having Formula (1) or (2), and methods for using such compounds. For example, the compounds of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibition of anaplastic lymphoma kinase (ALK) activity, c-ros oncogene (ROS), insulin-like growth factor (IGF-IR), and/or insulin receptor (InsR) or a combination thereof.

Title
Compounds and compositions as kinase inhibitors
Application Number
PCT/US2009/039380
Publication Number
2009/126514
Publication Date
October 15, 2009
Inventor
Zhu Xuefeng
Wu Baogen
Pei Wei
Nguyen Truc Ngoc
Michellys Pierre Yves
Jiang Tao
Agent
TONGO WU Emily
Assignee
Zhu Xuefeng
Wu Baogen
Pei Wei
Nguyen Truc Ngoc
Michellys Pierre Yves
Jiang Tao
Irm
View Original Source